Mitochondrial respiratory chain function in skeletal muscle of ALS patients

被引:56
作者
Echaniz-Laguna, A
Zoll, J
Ribera, F
Tranchant, C
Warter, JM
Lonsdorfer, J
Lampert, E
机构
[1] Hospices Civils Strasbourg, Serv Malad Syst Nerveux & Muscle, Neurol Clin, F-67091 Strasbourg, France
[2] Fac Med, Serv Physiol Clin & Explorat Fonct, Dept Physiol, Strasbourg, France
关键词
D O I
10.1002/ana.10357
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Evidence implicating mitochondrial dysfunction in the central nervous system of patients with sporadic amyotrophic lateral sclerosis (SALS) has recently been accumulating. In contrast, data on mitochondrial function in skeletal muscle in SALS are scarce and controversial. We investigated the in situ properties of muscle mitochondria in patients with early stage SALS and sedentary (SED) controls using the skinned fiber technique to determine whether respiration of muscle tissue is altered in early-stage SALS in comparison with SED. Musculus vastus lateralis biopsies were obtained from 7 SED group members and 14 patients with early stage SALS (mean disease duration, 9 months). Muscle fibers were permeabilized with saponine and then skinned and placed in an oxygraphic chamber to measure basal (V-0) and maximal (V-max) adenosine diphosphate-stimulated respiration rates and to assess mitochondrial regulation by adenosine diphosphate. Muscle oxidative capacity, evaluated with V-max, was identical in patients in the SALS and SED groups (V-0: SALS, 1.1 +/- 0.1; SED, 0.8 +/- 0.1, mumol 0(2) . min(-1) . gm(-1)dw and V-max: SALS, 3.1 +/- 0.3; SED, 2.5 +/- 0.3, mumol 0(2) . min(-1) . gm(-1)dw). This study shows an absence of large mitochondrial damage in skeletal muscle of patients with early-stage SALS, suggesting that mitochondrial dysfunction in the earlier stages of SALS is almost certainly not systemic.
引用
收藏
页码:623 / 627
页数:5
相关论文
共 39 条
[1]   ULTRASTRUCTURE OF ATROPHIC MUSCLE IN AMYOTROPHIC LATERAL SCLEROSIS [J].
AFIFI, AK ;
ALEU, FP ;
GOODGOLD, J ;
MACKAY, B .
NEUROLOGY, 1966, 16 (05) :475-&
[2]   Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid [J].
Andreassen, OA ;
Ferrante, RJ ;
Klivenyi, P ;
Klein, AM ;
Dedeoglu, A ;
Albers, DS ;
Kowall, NW ;
Beal, MF .
EXPERIMENTAL NEUROLOGY, 2001, 168 (02) :356-363
[3]   Mitochondria and the pathogenesis of ALS [J].
Beal, MF .
BRAIN, 2000, 123 :1291-1292
[4]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[5]  
Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO
[6]  
2-8
[7]   SUPEROXIDE-DISMUTASE ACTIVITY, OXIDATIVE DAMAGE, AND MITOCHONDRIAL ENERGY-METABOLISM IN FAMILIAL AND SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BOWLING, AC ;
SCHULZ, JB ;
BROWN, RH ;
BEAL, MF .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) :2322-2325
[9]   The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function [J].
Cedarbaum, JM ;
Stambler, N ;
Malta, E ;
Fuller, C ;
Hilt, D ;
Thurmond, B ;
Nakanishi, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 169 (1-2) :13-21
[10]   Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease [J].
Comi, GP ;
Bordoni, A ;
Salani, S ;
Franceschina, L ;
Sciacco, M ;
Prelle, A ;
Fortunato, F ;
Zeviani, M ;
Napoli, L ;
Bresolin, N ;
Moggio, M ;
Ausenda, CD ;
Taanman, JW ;
Scarlato, G .
ANNALS OF NEUROLOGY, 1998, 43 (01) :110-116